This compound is a chemical compound used as a pharmaceutical intermediate in the manufacturing of active pharmaceutical ingredients. It features an aromatic ether and a tertiary amine functional group.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 83015-25-2
Rac N-Methyl Atomoxetine Oxalate
Pharmaceutical intermediate for atomoxetine derivative
N-Nitroso-Atomoxetine
Nitrosamine impurity reference standard
N-[2-fluoro-6-(trifluoromethyl)benzyl]urea
Pharmaceutical intermediate
1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
Pharmaceutical intermediate
5-bromo-1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-6-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
Pharmaceutical intermediate
1,1-Dimethylethyl N-[(1R)-2-[5-bromo-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
pharmaceutical intermediate
N,N-dimethyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine
UCPQMRYBCNDVHU-UHFFFAOYSA-N
CC1=CC=CC=C1OC(CCN(C)C)C2=CC=CC=C2
—